Search research articles
お問い合わせ
Search research articles
Search
関連する実験動画
ブロモクリプチンと尿失禁
M Caine
Lancet (London, England)
|
January 28, 1984
日本語
まとめ
No abstract available in
PubMed
.
関連する概念動画
こちらも読む
関連記事
共著者、ジャーナル、引用グラフによってこの研究に関連する記事。
並び替え
すべて
12
Same author
6
Same journal
6
Same author
Creating IPR and design value.
Medical device technology
·
2004
Same author
Re: evaluation of an inspiratory muscle trainer in healthy humans (Respir Med 95: 526-531): critique of Hart et al.
Respiratory medicine
·
2002
Same author
A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction. 1978.
The Journal of urology
·
2002
Same author
Functional antagonistic activity of Rec 15/2739, a novel alpha-1 antagonist selective for the lower urinary tract, on noradrenaline-induced contraction of human prostate and mesenteric artery.
The Journal of pharmacology and experimental therapeutics
·
1996
Same author
Reflections on alpha blockade therapy for benign prostatic hyperplasia.
British journal of urology
·
1995
Same author
[Terazosine in the treatment of benign prostatic hypertrophy].
Journal d'urologie
·
1993
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)
·
2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)
·
2026
Same journal
Research priorities for characterising Bundibugyo virus.
Lancet (London, England)
·
2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)
·
2026
Same journal
Dual mobility total hip replacement in fractures: stability promotes patient confidence.
Lancet (London, England)
·
2026
Same journal
Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.
Lancet (London, England)
·
2026
関連記事をすべて見る